# Lacosamide

NDC: 65219-204
Generic name: Lacosamide
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220725

FDA application: ANDA214677

## Active ingredients

- LACOSAMIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=419ff519-2b19-4fb9-adfa-868ba0229407